available faster than those of viral cultures. Speed to result allows medical professionals to prescribe antiviral agents and perform appropriate infection control more rapidly. Lastly, NAAT does not need a strict transportation protocol for maintaining viability of RV. 3 In addition, the application of multiplexing technology in NAAT allows better detection than classical methods of a broad range of viruses. For all of these reasons NAAT has replaced classical methods.
There are a number of commercial multiplex kits that can detect between 12 and 23 virus types. 3, 4 Performance evaluation studies for newly developed multiplex RV kits are weak, do not establish the ref-
erence standard method and therefore do not sufficiently calculate sensitivity and specificity of each test. Instead, some studies have suggested the reference test with in-house multiplex real-time PCR or commercial duplex PCR tests. [5] [6] [7] [8] We performed a direct comparison of three commercial multiplex assays and produced the values of the agreement and kappa instead of sensitivity and specificity with the reference tests. The objective of this study was to perform a direct comparison of three multiplex RT-PCR assays for the detection of respiratory viruses.
| MATERIALS AND METHODS

| Clinical samples
Respiratory samples used in this study were collected between Clinical samples from 201 young male soldiers (age range 18-27 years, median 21 years) with acute respiratory illness were randomly selected for study without knowledge of previous results from Real-Q RV or Anyplex II RV16 tests. They consisted of nasopharyngeal (NP) swab samples (n=161) and sputum samples (n=40) and were stored at −70°C until this study was conducted.
Nasopharyngeal swab samples were obtained using flocked swabs and transported in 3 mL universal transport medium (COPAN Diagnostics, Murrieta, CA, USA). Sputum samples were received in sterile plastic containers and treated in order to homogenize samples using a 1:1 ratio dithiothreitol, which was diluted 1:100 with distilled water because of it viscosity. This study was approved by the Ethics Committee of Armed Forces Medical Command (AFMC-16-IRB-023).
| Nucleic acid extraction
The nucleic acid extraction system was used for each RV assay. For 
| Multiplex RT-PCR assays
Three commercial multiplex RV assays were performed based on manufacturers' protocols. Characteristics of the three multiplex assays are briefly reported in Table 1 
| Discrepant result analysis
A flow diagram of discrepant analysis is described in Figure 1 . In sum- between original and additional tests showed a discordance, they were considered to be a negative consensus. Because both AD and RQ assay cannot detect PIV4 and EV, the results about PIV4 and EV were excluded from the discrepant analysis. 
| Statistical analysis
| RESULTS
Statistical analysis using percent agreement between RV assays in each virus type were high, ranging from 94% to 100%. Overall agreement between three RV assays ranged from 97% to 98%. with AD by monoplex PCR followed by direct sequencing. For the 36 discrepant virus results, additional testing revealed that 18.8% (3/16), 55.6% (10/18), and 50.0% (1/2) were consistent with the original virus result of AP, AD, and RQ assays respectively. These results were considered positive (Table 3) .
Of the 201 samples, AP, AD, and RQ detected 103 (51.2%), 99 (49.3%), and 95 (47.3%) positive cases respectively (Table 4 ). Viral coinfection samples were identified in AP assay for 24 (11.9%) patients, in AD assay for 17 (8.5%) patients, and in RQ assay for 11 (5.5%) patients. In the co-infected samples: two viruses were detected in 24 patients by AP assay; two viruses were detected in 14 patients and three viruses in three patients by AD assay; two viruses were detected in 11 patients by RQ assay. INF A was the most commonly detected virus by co-infected samples, followed by ADV, RSVB, MPV and etc.
Overall distribution of respiratory viruses from 3 RV assays is presented in Table 4 . There are indications of the predominance of INFA, ADV, HRV, and MPV. Excluding these four major types, the rest of RV types accounted for only 0.8% to 8.9% of total viruses identified.
| DISCUSSION
The current study was performed for direct comparison between commercial multiplex RT-PCR for detection of respiratory viruses. A high degree agreement was found between AP, AD, and RQ assays. In real circumstances of a clinical laboratory, the introduction of multiplex RT-PCR assay for detection of RV was considered based on the assay's performance data and user friendliness. 2, 3, 12 The assay characteristics of 3 RV assays related to end-users was briefly summarized in Table 1 reverse transcription followed by real-time PCR in a closed system.
The test result of all assays was automatically presented by free analysis software offered from each company. The selection of multiplex RT-PCR assay for RV detection requires consideration of each laboratory's facility, human resources and the number of tests.
To the best of our knowledge there is no study that compares Anyplex II RV16, AdvanSure RV, and Real-Q RV in young adult patients with acute respiratory illness. Among the three assays, performance evaluation of AP assay was discussed in a number of articles. A first evaluation of AP assay against a combined standard of AP, xTAG
Respiratory Viral Panel and Seeplex RV15 reported 95.2% sensitivity and ≥98.6% specificity rate. 13 About the same time, Cho et al. 14 reported that the performance of AP was superior in comparison with viral culture and Seeplex RV15. Huh et al. 15 analyzed agreement between AP and Seeplex RV12 without standard method and found that the AP assay produced an equivalent performance against Seeplex RV12. The result of present study also showed that AP assay produced good agreements in performance comparable with AD and RQ assay in performance. In a previous study, AD showed good agreement (98%) against conventional multiplex RT-PCR. 16 Similarly, the performance evaluation of AD vis-à-vis a composite standard method revealed the most sensitive performance compared with viral culture and Seeplex
RV15
. 17 The performance study of RQ assay was not found in the pubmed database, but evaluation of a previous version (1-step RV real-time PCR) against direct sequencing as a standard method reported 94.1% sensitivity and 96.6% specificity. 18 We demonstrated that the agreement between three assays was excellent. Moreover, the end-user in clinical laboratories selecting the multiplexed RT-PCR for RV will need to consider the benefits of each assay in terms of both performance and user-friendliness.
In the analysis of discrepant samples, 18.8% (3/16) from AP, 55.6%
(10/18) from AD, and 50.0% (1/2) from RQ were consistent with the original virus results (Table 3) . Of note, when repeat AP assay was done all RSVB samples (n=11) with an initial positive result by single AP identified as negative. Original test results of these samples were presented as + positive as detected by a melting temperature analysis after 50 cycles because they were supposed to contain low virus concentration. Unfortunately, the manufacturing company does not provide target range for virus detection and discloses that AP is a qualitative test for the detection of RV.
Likewise, samples of CoV 229E identified as positive by single AD assay identified as negative (80%, 4/5) from result of monoplex PCR followed by direct sequencing. Negative samples had a high C t (threshold cycle) value (mean±SD, 25.17±1.19) close to 27.0 as a cut-off value, whereas one identified as positive using AD assay had a low C t value (23.1). These findings suggest that the discordant results were frequently reported in samples containing low viral copy.
Other studies also indicated that discrepant results between RV assay was quite associated with sample's viral load. In conclusion, the agreement of the three assays were very good, with 94%-100% agreement for all comparisons. We suggest that all multiplex assay would be suitable for the detection of for respiratory viruses in clinical setting. 
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